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Preliminary Assessment of Diabetic Youth’s
Acceptance of Cinnamon in Treating Diabetes:
A Telephone Interview
Jay Kandiah
Dawn Vincent
Valerie Amend
Kimberli Pike
Ball State University
Medications in treatment and control of diabetes can be costly for pediatric
patients and families. Therefore, individuals may seek complementary and
alternative therapies, such as cinnamon, in addition to traditional treatments.
The objective of this study was to determine acceptability of using cinnamon in
treatment of diabetes in a pediatric population with diabetes. Seventy-six
pediatric diabetes patients at a diabetes clinic participated in a one-time
telephone interview using an 18-item, validated questionnaire. Descriptive
statistics were utilized to determine cinnamon acceptability and preferences. The
majority of the subjects were between 16-18 years (43%, n = 33), Caucasian
(62%, n = 47), and female (67%, n = 51). More than three-fourths were
overweight or at risk of being overweight (80%, n = 60). Seventy-six percent
stated that they would be willing to try cinnamon for treatment of their diabetes,
whereas 14.5% were undecided and 9.2% unwilling. Most (n = 56, 52.5%) were
willing to take the cinnamon supplement 1-2 times per day. The greatest concerns
expressed by subjects were side effects, interaction with current medications, and
physician’s willingness to approve and prescribe. This research suggests that in
consultation with health professionals, diabetic youth are willing to try cinnamon
supplementation in the treatment of diabetes.
Keywords: Diabetes, pediatrics, cinnamon, interview
Introduction
According to a 2010 report from the Centers for Disease Control and Prevention (CDC, 2011), in
the United States, about 215,000 people under age 20 have diabetes; this is 0.26% of individuals
in this age group. Each year from 2002-2005, 15,600 youth were newly diagnosed with type 1
diabetes, and 3,600 were newly diagnosed with type 2 diabetes. Diabetes is associated with
higher risks of morbidity and mortality and is the 5th leading cause of death in America
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(American Association of Diabetes Educators, 2012). Individuals with diabetes have two times
the risk of death compared to individuals without diabetes (CDC, 2011). Diabetes is associated
with a number of complications that intensify with duration of the condition and is the leading
cause of kidney failure, nontraumatic lower-limb amputations, and new cases of blindness
among adults (CDC, 2011). Cardiovascular disease accounts for approximately 25% of deaths
among patients with onset of diabetes before 20 years of age (American Association of Diabetes
Educators, 2012). Heart disease and stroke account for about 65% of deaths among all people
with diabetes (American Association of Diabetes Educators, 2012).
Individuals with diabetes aim to maintain proper control of their blood glucose and lipid levels to
prevent related complications. Methods to control these levels can include a controlled diet,
exercise regimen, weight loss, oral medications, and/or insulin (CDC, 2011).
Medications in treatment and control of diabetes can be costly, and their long-term safety is
questionable (Eisenberg et al., 1993). Therefore, individuals may seek complementary and
alternative therapies such as use of spices and herbs (e.g., cinnamon, ginseng, davana, supari,
and aloe vera) in addition to traditional treatments. Several studies have examined the use of
complementary and alternative medicine (CAM) in treatment of diabetes in adults (Broadhurst,
Polansky, & Anderson, 2000; Egede, Ye, Zheng, & Silverstein, 2002; Garrow & Egede, 2006;
Jarvill-Taylor, Anderson, & Graves, 2001; Khan, Bryden, Polansky & Anderson, 1990; Khan &
Safdar, 2003; Ryan, Pick, & Marceau, 2001; Schoenberg, Stoller, Kart, Perzynski, & Chapleski,
2004; Shapiro & Gong, 2002; Yeh, Eisenberg, Davis, & Phillips, 2002; Yeh, Eisenberg,
Kaptchuk, & Phillips, 2003).
Recently, more studies have focused on cinnamon supplementation, specifically in adult
diabetics (for example Crawford, 2009; Klein et al., 2005; Magistrelli & Chezem, 2012; Vafa et
al., 2012), with varying results. While an analysis of ten prospective, parallel-group design,
randomized controlled trials on cinnamon and diabetes by Leach and Kumar (2012) found there
was not sufficient evidence to support the use of cinnamon for type 1 or 2 diabetes, studies by
Hlebowicz, Darwiche, Björgell, and Almér (2007) and Magistrelli and Chezem (2012) suggest
cinnamon may be effective in moderating postprandial glucose response in normal weight and
obese adults. Altschuler, Casella, MacKenzie, and Curtis (2007) found the use of cinnamon does
not produce significant improvements in Hemoglobin A1c (HbA1c) for type 1 diabetes, as the
disease has different pathophysiology than type 2 diabetes. Still, the number of type 2 diabetes
diagnoses in populations under the age of 20 has climbed. To date, little research has examined
the efficacy of using cinnamon with the pediatric population or the willingness of diabetic youth
to use cinnamon for treatment of diabetes. Therefore, the purpose of this descriptive pilot study
was to determine youth’s preference and acceptability of cinnamon as a complementary therapy
in treatment of diabetes.
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Materials and Methods
One-hundred and seventy-seven pediatric patients who attend or have previously attended a
diabetes clinic at a large Midwestern children’s hospital were invited to participate in the study.
Names and contact information of the participants were obtained from the clinic’s pediatric
endocrinologist. Subjects’ inclusion criteria for the study included the following: 1) age 10-18
and 2) diagnosed with either type 1 or type 2 diabetes for over 1 year. Patients who were
pregnant were excluded from this study. Prior to data collection, parental-patient consent was
obtained for release of all pertinent medical information.
An 18-item telephone interview questionnaire (12 questions related to cinnamon use and
diabetes; 6 demographic questions) was used as a script. The interview questions were reviewed
by one endocrinologist, two pediatric dietitians, and two parents for face validity to ensure
appropriateness for the pediatric population. Reliability was not assessed because the interview
questionnaire was simply measuring conditions and opinions of youth diabetic patients via
telephone; actual use of cinnamon was not assessed. Upon approval of the study protocol from
the Institutional Review Board, a one-time telephone interview was conducted using the
questionnaire. A single researcher conducted all interviews to ensure uniformity in questions.
Heights and weights were retrieved from subject’s most recent medical records. Descriptive
statistics were computed using SPSS software. Further statistical analysis was not utilized due to
the preliminary nature of the study and relatively small sample size. Also, researchers were not
looking at effectiveness of cinnamon, rather acceptance with the population described.
Results
From a pool of 177 pediatric diabetic patients, 76 successfully completed the research. Of the
remaining 101 potential subjects, 97 could not be contacted due to disconnection of telephone
services, incorrect numbers, and/or lack of telephone accessibility. Two patients were over 18
years of age, and two denied having diabetes.
As shown in Table 1, 67% (n = 51) were female, and 33% (n = 25) were male. A majority of
subjects were age 16-18 years (43%, n = 33) and Caucasian (62%, n = 47). Other ethnicities
represented were African American (n = 25), Asian (n = 2), Latino (n = 1), or mixed (n = 1).
Calculation of Body Mass Index for Age indicated 20% of children (n = 15) were at a healthy
weight, 25.3% (n = 19) were at risk for overweight, and 54.7% (n = 41) were overweight.
Table 2 presents descriptive statistics related to the current health regimen of participants,
including type of diabetes, special diets used, and types and frequency of medications used to
control diabetes. The most commonly used types of insulin were Novolog (n = 24, 31.6%) and
Lantus (n = 16, 21.1%). Metformin was the most used oral medication (n = 51, 67.1%).
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Table 1. Demographic Information of Subjects (N = 76)
n (%)
Gender
Female
Male
Age
10-12
13-15
16-18
Ethnicity
African American
Asian
Latino
Mixed
Caucasian

51 (67.1)
25 (32.9)
16 (21.1)
27 (35.5)
33 (43.4)
25 (32.9)
2 (2.6)
1 (1.3)
1 (1.3)
47 (61.8)

Table 2. Current Health Regimen of Participants (N = 76)
n (%)
Type of Diabetes
Type 1
24 (31.6)
Type 2
52 (68.4)
Type of Diet Used
1500-1800 ADA
2 (2.6)
Carbohydrate Counting
23 (30.3)
Eat Less Food
6 (7.9)
Eat Less Sweets
3 (3.9)
Limit Carbohydrates
2 (2.6)
Low Carb/Low Fat
1 (1.3)
No Regular Soda
1 (1.3)
Type Not Provided
2 (2.6)
No Special Diet Used
36 (47.3)
Type of Medication
Actose
5 (6.6)
Amaryl
2 (2.6)
Byetta
1 (1.3)
Humalog/Humulin
16 (21.1)
Lantus
16 (21.1)
Lente
2 (2.6)
Levamir
1 (1.3)
Metformin
51 (67.1)
Novolog
24 (31.6)
NPH
5 (6.6)
Note: Some participants were taking more than one medication.
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Over three-fourths of youth (76.3%, n = 58) stated that they would be willing to try cinnamon for
treatment of their diabetes, whereas 14.5% (n = 11) were undecided, and 9.2% (n = 7) were
unwilling to try (see Table 3). When questioned on their preference for the type of supplement
(e.g., pill, liquid, either) and frequency of use, the majority of those who were willing to try
cinnamon or were undecided stated they would prefer a pill. Interestingly, more than 30%
(34.2%, n = 26) were willing to try either the pill or liquid form of the supplement. More than
50% (60.5%, n = 46) were willing to take the cinnamon supplement 1-2 times per day. A small
proportion (2.6%, n = 2) expressed a desire to take it an unlimited number of times daily. When
asked if cinnamon could help control blood glucose levels, the majority of youth were
undecided, while a little over one-third stated yes.
Table 3. Participants’ Supplement Preferences (N = 76)
n (%)
Willing to Try Cinnamon
Yes
No
Undecided
Supplement Form
Pill
Liquid
Either
Neither
Times per Day
0
1
2
3
4
5
6
Unlimited

58 (76.3)
7 (9.2)
11 (14.5)
30 (39.5)
13 (17.1)
26 (34.2)
7 (9.2)
7 (9.2)
18 (23.7)
28 (36.8)
14 (18.4)
5 (6.6)
1 (1.3)
1 (1.3)
2 (2.6)

In response to diabetic adolescents, concerns regarding the use of cinnamon, the greatest
concerns were side effects (72.4%, n = 55) and interaction with current medications (64.5%,
n = 49). The least concern was number of times the cinnamon supplement would have to be
taken each day. Other concerns reported by participants that may influence consideration of
cinnamon supplement included: 1) the effect on physiological bodily functions (e.g., eyesight,
organs, weight, and nerve impairment) and medical conditions (e.g., asthma, allergies, and
dermatological issues); 2) palatability (e.g., taste alteration); 3) effectiveness of supplement; and
4) physicians’ willingness to approve and prescribe (see Table 4).

Journal of Human Sciences and Extension

Journal of Human Sciences and Extension

Volume 1, Number 2, 2013

Volume 1, Number 2, 2013

Youth’s Acceptance of Cinnamon in Treating Diabetes

6

Youth’s Acceptance of Cinnamon in Treating Diabetes

68

Table 4. Potential Concerns Expressed by Participants
Regarding Cinnamon Supplement Use (N = 76)
n (%)
Side Effects
Yes
No
Cost
Yes
No
Insurance Coverage
Yes
No
Number of Times Taken Per Day
Yes
No
Interaction with Current Medications
Yes
No
Other
Yes
No

55 (72.4)
21 (27.6)
45 (59.2)
31 (40.8)
39 (51.3)
37 (48.7)
29 (38.2)
47 (61.8)
49 (64.5)
27 (35.5)
8 (10.5)
68 (89.5)

Discussion
Limited investigations have been conducted regarding diabetic youth’s acceptability of cinnamon
as treatment for diabetes. However, several studies have looked at complementary and
alternative (CAM) medicine use and the effectiveness of cinnamon. Research by Low, Murray,
O’Mahony, and O’B Hourihane (2008) looked at the prevalence of CAM use among the
pediatric population in Ireland. Questionnaires were distributed over 4 months to 13 pediatric
settings. Researchers found 57% of parents reported using CAM for their child, with the highest
usage reported in 2-4 year olds. A similar study conducted in 2010 by Birdee, Phillips, Davis,
and Gardiner examined factors associated with pediatric use of CAM in the United States. They
found pediatric CAM users (n = 9,417) were more likely to be adolescents (AOR 1.36 [1.021.80], to have a parent who used some form of CAM (AOR 3.83 [3.04-4.84], and more likely to
take prescription medications (AOR 1.51 [1.19-1.92]). A Finnish study by Hämeen-Anttila,
Niskala, Siponen, and Ahonen (2011) examined the use of CAM among the parents of children
under the age of 12 to determine parents’ influence on the children’s future use. The study
examined 4,032 surveys. Thirty-one percent of subjects reported using some type of CAM in the
preceding two days. Researchers concluded that women over 30 years of age, with higher
education and higher incomes, were more likely to use CAM.
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Research most similar to the present study was conducted in 2005 by Klein et al. (2005) and
explored adolescents’ knowledge of and beliefs about dietary supplements, herbs, and over-thecounter medications. Subjects included 81 adolescents from various groups: suburban
adolescents, urban minority adolescents, adolescents with chronic illness (including diabetes),
and patients of complementary and alternative medicine practitioners. Focus group results
indicated that most adolescents understood the terms “herbal medicine,” “herbal remedies,” or
“nutritional supplements,” but many were unfamiliar with the term “alternative medicine.” In
addition, most adolescents were familiar with CAM therapies used by people from their own
culture, and most linked use of CAM for treatment of illness rather than preventative care.
The effectiveness of cinnamon as an alternative or adjunctive therapy for blood glucose control
in the adult population has been studied in recent years, with varying results. Crawford (2009)
utilized a randomized controlled trial to determine the effectiveness of cinnamon in lowering
Hemoglobin A1c (HbA1c) levels in 109 patients with type 2 diabetes. The control group
received usual medical care, while the experimental group received medical care in addition to
cinnamon capsules. Results indicated HbA1c levels in the experimental group were lowered by
0.83% (95% CI, 0.4601.2) compared to usual care lowering of HbA1c by 0.37% (95% CI, 0.150.59). Vafa et al. (2012) examined the effects of cinnamon consumption on glycemic status of
44 patients with type 2 diabetes in a double-blind placebo-controlled study. They found no
significant differences in glycemic indicators between the placebo and treatment groups.
Research conducted by Hlebowicz et al. (2007) investigated the effect of cinnamon on
postprandial glucose in 14 healthy subjects using a crossover trial. Results indicated the addition
of 6 grams of cinnamon to a meal lowered the postprandial glucose response (p < 0.05). The
recent study from Magistrelli and Chezem (2012) found the addition of 6 grams of cinnamon to
the cereal significantly reduced 120-minute glucose AUC (p=0.008) and blood glucose at 15 (p =
0.001), 30 (p < 0.001), 45 (p < 0.001), and 60 (p = 0.001) minutes. At 120 minutes, blood
glucose was significantly higher with cinnamon consumption (p < 0.001) compared to a control
group.
The present study was unique for several reasons: 1) diabetic youths’ perceptions on cinnamon
use was gathered using telephone interviews; 2) it is one of the few to examine the pediatric
diabetic population’s acceptance of cinnamon in regulation of blood glucose levels; and 3) in
addition to information on current usage, this research obtained detailed information on mode of
administration (including form and frequency) and potential concerns reported by diabetic youth
with the use of cinnamon as CAM. There were limitations to this pilot study, including the
sample selection which was confined to diabetic children and adolescents at one hospital with
telephone accessibility. The use of a closed-ended questionnaire could lead to bias, and parents
may have influenced the participants and possibly their answers to interview questions. Future
research could focus on a qualitative inquiry to further explore the results of the present study,
with additional statistical analysis.
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The rise in diabetes in the pediatric population has encouraged health professionals to examine
alternative forms of treatment. When compared to conventional therapies, it is possible that
utilization of cinnamon may be beneficial in diabetes control resulting in greater patient
compliance with decreased side effects. While it is premature to recommend cinnamon as a
treatment for pediatric diabetes based on lack of research with this population, this preliminary
study suggests that in consultation with health professionals, diabetic youth are willing to try
cinnamon in the form of a pill as an alternative (or in conjunction with traditional medical care)
in the treatment of diabetes.
Diabetes management is a collaborative effort and alternative treatments add another avenue to
address the growing issue of pediatric diabetes. Barriers may be addressed by working with
community organizations, hospitals and schools to disperse information on new treatments as
they become available. Should research continue to support improved outcomes with the use of
cinnamon for blood glucose control in type 2 diabetes, it is important to know if prospective
patients would be open to utilizing new methods of treatment. The findings of the present study
reveal that the majority would be open to trying cinnamon if it is proven a reliable treatment.
Therefore, randomized clinical trials with this population would be recommended to determine
the efficacy of using cinnamon as a complementary treatment for diabetes.
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